PT - JOURNAL ARTICLE AU - Adam, Dayani AU - Balan, Ramkumar T. AU - Ismail, Abbas TI - Disparities in adherence to antiretroviral therapy of the selected subpopulations among adults living with HIV/AIDS in Tanzania. Analysis of a population-based survey 2016-17 AID - 10.1101/2023.08.24.23294553 DP - 2023 Jan 01 TA - medRxiv PG - 2023.08.24.23294553 4099 - http://medrxiv.org/content/early/2023/08/25/2023.08.24.23294553.short 4100 - http://medrxiv.org/content/early/2023/08/25/2023.08.24.23294553.full AB - Adherence is a critical component of successful HIV treatment among people living with HIV/AIDS. It is essential for achieving and maintaining viral suppression, which is the primary goal of HIV care and treatment. The objective of this study was to assess the disparity of the treatment adherence of selected subpopulations among HIV adult patients in Tanzania. The study used a cross-sectional survey of 792 adults living with HIV/AIDS from 31 regions in Tanzania. A two-stage stratified cluster design was used in this survey and included jackknife replicate sampling weights. Frequency tables displaying frequencies, weighted proportions, and confidence intervals were employed to depict socio-demographics by treatment adherence. Treatment adherence was calculated by subtracting missed doses from prescribed doses, dividing the result by the prescribed dosage, and multiplying by 100 to establish a percentage. Rao-Scott chi-square was used to produce the weighted proportions of the adherence within subpopulations. Also, the Adjusted Wald Test was used to examine whether or not the subpopulations are similar to or different in terms of their level of treatment adherence. The results showed that there was a significant difference in treatment adherence between the selected subpopulations. The majority of the selected subpopulations, including those based on age, sex, marital status, and level of education, were found to have disparities in the level of treatment adherence. However, the study also revealed no disparities in treatment adherence between urban and rural settings, married and widowed, age groups of 25 to 34, and those of 55 and over. The study’s findings revealed considerable disparities in treatment adherence between various subpopulations, emphasizing the necessity for specifically developed interventions to address these disparities to attain better health outcomes among adults living with HIV/AIDS.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge that the research presented in this submission was carried out by a researcher who self-identifies as having low financial resources. While conducting this work, the author was not connected to any academic or research organizations. For this study, no outside grants or money were obtained. The study, along with any related expenses like data collecting, analysis, and paper preparation, was paid for entirely by the author. We thus state that there are no commercial donors or financing sources to be disclosed. The author's personal commitment to expanding public health knowledge and interest drove the sole motivation for this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol underwent rigorous review and approval by the institutional review boards (IRBs) of Columbia University Medical Center, Westat, CDC, the National Institute for Medical Research, and the Zanzibar Medical Research and Ethics Committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes